---
figid: PMC9167127__JIR2022-8071234.001
pmcid: PMC9167127
image_filename: JIR2022-8071234.001.jpg
figure_link: /pmc/articles/PMC9167127/figure/fig1/
number: Figure 1
figure_title: ''
caption: Th22 cells increased in PBMCs obtained from NSCLC patients. (a) The leukocytes
  isolated from the peripheral blood obtained from 31 patients with lung cancer and
  10 healthy controls were analyzed by flow cytometry. The percentage of CD4 + IL-22 + IL-17-
  cells is shown. The numbers indicated in the lower right box represent the average
  values for the different groups.
article_title: Th22 Cells/IL-22 Serves as a Protumor Regulator to Drive Poor Prognosis
  through the JAK-STAT3/MAPK/AKT Signaling Pathway in Non-Small-Cell Lung Cancer.
citation: Yinan Yao, et al. J Immunol Res. 2022;2022:8071234.
year: '2022'

doi: 10.1155/2022/8071234
journal_title: Journal of Immunology Research
journal_nlm_ta: J Immunol Res
publisher_name: Hindawi

keywords:
---
